Edward Adomako: Recognizing Thrombotic Thrombocytopenic Purpura as A Life-Threatening Emergency
Edward Adomako, Biochemist and Molecular Biologist, shared on LinkedIn:
”Thrombotic Thrombocytopenic Purpura (TTP): A Rare but Life-Threatening Medical Emergency
In clinical laboratory medicine, some conditions demand rapid recognition and immediate intervention.
One of these is Thrombotic Thrombocytopenic Purpura (TTP), a rare disorder that can become fatal if not treated promptly.
TTP occurs when there is a severe deficiency of the enzyme ADAMTS13, which normally regulates von Willebrand factor in the blood.
When this enzyme is lacking, abnormal platelet clumping can occur in small blood vessels, leading to microvascular thrombosis.
Key laboratory and clinical features include:
- Severe thrombocytopenia (low platelet count)
- Microangiopathic hemolytic anemia with schistocytes on peripheral smear
- Elevated LDH and bilirubin
- Neurological symptoms such as confusion or seizures
- Possible renal impairment
Historically, clinicians described a ‘pentad’ of symptoms, but in many cases, the combination of thrombocytopenia and hemolytic anemia is enough to raise strong suspicion.
Why early diagnosis matters
Without treatment, mortality from TTP can be extremely high.c
Fortunately, modern therapies such as therapeutic plasma exchange, corticosteroids, and targeted therapies like caplacizumab have dramatically improved survival rates.
The role of the laboratory
Laboratory professionals play a critical role in identifying:
- Schistocytes on peripheral blood smear
- Evidence of hemolysis
- ADAMTS13 activity testing when available
Early laboratory detection can be the difference between rapid life-saving treatment and delayed care.
For healthcare professionals:
Maintaining a high index of suspicion when encountering unexplained thrombocytopenia and hemolytic anemia is crucial.
As laboratory and healthcare professionals, our vigilance helps ensure that rare but critical conditions like TTP are recognized and treated in time.”

Stay updated with Hemostasis Today.
-
Oct 10, 2026, 09:05Wolfgang Miesbach: Moving from Bleed Control to Comprehensive Joint Health
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness
-
Oct 10, 2026, 07:12Hamzah Khan: The Role of Genuine Curiosity in Driving High-Impact Academic Research
-
Oct 10, 2026, 06:58Nita Radhakrishnan: Turning Evidence Into Action for Hemophilia Care in India
-
Oct 10, 2026, 06:48Nutan Kaushik: HemeNext 2.0 Brings Global Perspectives to Hematology
-
Oct 10, 2026, 06:43Suthesh Sivapalaratnam: Advancing Bleeding Disorder Care at EHC 2026
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage